MedPath
FDA Approval

BROMSITE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
April 14, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Bromfenac(0.76 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Woodstock Sterile Solutions, Inc.

Sun Pharmaceutical Industries, Inc.

117895702

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

BROMSITE 0.075%

Product Details

NDC Product Code
49708-754
Application Number
NDA206911
Marketing Category
NDA (C73594)
Route of Administration
OPHTHALMIC
Effective Date
April 14, 2023
BromfenacActive
Code: 8ECV571Y37Class: ACTIMQuantity: 0.76 mg in 1 mL
BORIC ACIDInactive
Code: R57ZHV85D4Class: IACT
SODIUM BORATEInactive
Code: 91MBZ8H3QOClass: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACT
POLOXAMER 407Inactive
Code: TUF2IVW3M2Class: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
POLYCARBOPHILInactive
Code: W25LM17A4WClass: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7Class: IACTQuantity: 0.05 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath